Literature DB >> 20035332

Primary Raynaud phenomenon and small-fiber neuropathy: is there a connection? A pilot neurophysiologic study.

Nisha J Manek1, Aaron R Holmgren, Paola Sandroni, Thomas G Osborn, Mark D P Davis.   

Abstract

The pathophysiologic factors of primary Raynaud phenomenon (RP) are unknown. Preliminary evidence from skin biopsy suggests small-fiber neuropathy (SFN) in primary RP. We aimed to quantitatively assess SFN in participants with primary RP. Consecutive patients with an a priori diagnosis of primary RP presenting to our outpatient rheumatology clinic over a 6-month period were invited to participate. Cases of secondary RP were excluded. All participants were required to have normal results on nailfold capillary microscopy. Assessment for SFN was accomplished with autonomic reflex screening, which includes quantitative sudomotor axonal reflex test (QSART), and cardiovagal and adrenergic function testing, thermoregulatory sweat test (TST), and quantitative sensory test (QST) for vibratory, cooling, and heat-pain sensory thresholds. Nine female participants with a median age of 38 years (range 21-46 years) and a median symptom duration of 9 years (range 5 months-31 years) were assessed. Three participants had abnormal results on QSART, indicating peripheral sudomotor autonomic dysfunction. Two participants had evidence of large-fiber involvement with heat-pain thresholds on QST. Heart rate and blood pressure responses to deep breathing, Valsalva maneuver, and 70° tilt were normal for all participants. Also, all participants had normal TST results. In total, three of the nine participants had evidence of SFN. The presence of SFN raises the possibility that a subset of patients with primary RP have an underlying, subclinical small-fiber dysfunction. These data open new avenues of research and therapeutics for this common condition.

Entities:  

Mesh:

Year:  2009        PMID: 20035332     DOI: 10.1007/s00296-009-1293-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

1.  Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes.

Authors:  J D Stewart; P A Low; R D Fealey
Journal:  Muscle Nerve       Date:  1992-06       Impact factor: 3.217

Review 2.  Clinical practice. Raynaud's Phenomenon.

Authors:  Fredrick M Wigley
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

3.  Laboratory evaluation of autonomic function.

Authors:  Phillip A Low
Journal:  Suppl Clin Neurophysiol       Date:  2004

4.  Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon.

Authors:  F Khan; S J Litchfield; M McLaren; D J Veale; R C Littleford; J J Belch
Journal:  Arthritis Rheum       Date:  1997-02

5.  Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group.

Authors:  P J Dyck; P J Dyck; T S Larson; P C O'Brien; J A Velosa
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

6.  Comparison of different modalities for detection of small fiber neuropathy.

Authors:  K Tobin; M J Giuliani; D Lacomis
Journal:  Clin Neurophysiol       Date:  1999-11       Impact factor: 3.708

7.  Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon.

Authors:  C B Bunker; C Reavley; D J O'Shaughnessy; P M Dowd
Journal:  Lancet       Date:  1993-07-10       Impact factor: 79.321

8.  Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia.

Authors:  Mark D P Davis; Paola Sandroni; Thom W Rooke; Phillip A Low
Journal:  Arch Dermatol       Date:  2003-10

Review 9.  Raynaud's phenomenon: a proposal for classification.

Authors:  E C LeRoy; T A Medsger
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

10.  Autonomic involvement in extrapyramidal and cerebellar disorders.

Authors:  P Sandroni; J E Ahlskog; R D Fealey; P A Low
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

View more
  2 in total

1.  Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

Authors:  Sarah L Kerns; Chunkit Fung; Patrick O Monahan; Shirin Ardeshir-Rouhani-Fard; Mohammad I Abu Zaid; AnnaLynn M Williams; Timothy E Stump; Howard D Sesso; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair Beard; Robert A Huddart; Jeri Kim; Christian Kollmannsberger; Deepak M Sahasrabudhe; Ryan Cook; Sophie D Fossa; Lawrence H Einhorn; Lois B Travis
Journal:  J Clin Oncol       Date:  2018-04-04       Impact factor: 44.544

2.  Autonomic nervous system activity in primary Raynaud's phenomenon: Heart rate variability, plasma catecholamines and [123 I]MIBG heart scintigraphy.

Authors:  Lotte Lindberg; Louise S Brinth; Marianne L Bergmann; Bent Kristensen; Tine W Hansen; Philip Hasbak; Jane F Thomsen; Ebbe Eldrup; Lars T Jensen
Journal:  Clin Physiol Funct Imaging       Date:  2021-12-31       Impact factor: 2.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.